Human brain organoid studies demonstrated significant improvement in neuronal growth, morphology, and function; These findings highlight the potential of the porosome – a centra ...

RAD101 is the Company’s novel imaging small molecule that targets fatty acid synthase (FASN), a multi-enzyme protein that catalyses fatty acid synthesis and is overexpressed in many solid tumors, ...

The documented technical foundation supports a Q1 2026 commercial launch featuring Digital Landia's B2C AgenticPet app and PetVivo's B2B veterinary platform with white-labeled AI diagnostic assistance ...

CONSHOHOCKEN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor ...

Shareholders are advised to vote their shares well in advance of the proxy voting deadline of 11:59 p.m. ET, on November 23, 2025. The proposals are included in the definitive proxy statement filed ...

The Alpha Select Conference is invitation only. To request a meeting with Mr. Kohli, please contact your Craig-Hallum representative.

New Real-World Data support the effect of D-cycloserine (NRX-101 active ingredient) in doubling the effectiveness of Transcranial Magnetic Stimulation (TMS). Company has expanded access program for ...

ADVANCED-2 (NCT05951179) is a Phase 2 open-label trial assessing intravesical TARA-002 in NMIBC patients with carcinoma in situ or CIS (± Ta/T1) who are Bacillus Calmette-Guérin (BCG)-Unresponsive ...

The summit includes presentations, fireside chats and innovative panel discussions, moderated by members of the TD Cowen research team, that focus on various aspects of obesity and related disorders.

The Donor Selection & Cell Source Summit, hosted by Hanson Wade, brings together leaders from industry and academia to address critical bottlenecks in donor screening, cell sourcing, and process ...

Paris, 17 novembre 2025. À l'occasion du premier sommet Choose France dédié aux entreprises françaises, Sanofi confirme la place essentielle de la France dans sa stratégie industrielle, scientifique e ...

NextCure intends to use the net proceeds from the offering for general working capital needs, extending the company’s cash runway into the first half of 2027, which is beyond the planned first half of ...